Aril Pharma Limited
About Aril Pharma Limited
Data last updated:
Aril Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 2002.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2002PLC137788.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15.45 Lakh. It is led by directors including Vaibhav Purnandu Jain and Anupama Purnandu Jain.
Its last annual general meeting (AGM) was held on 30 September 2011, and its latest financial statements are for the year ended 31 March 2011. The registered office is at C – 302 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per MCA filings, the company has satisfied charges of ₹19 Cr on record. Court records list 6 cases involving the company, including 6 filed against it.
Company details
Contact details
Aril Pharma Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressC – 302 Crystal Plaza Andheri Link Road Andheri (West), Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aril Pharma Limited
FY 2011 filings availableFinancial Statement Summary
| Metrics | FY 2010-11 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2010-11 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Aril Pharma Limited, buy the company report.
Board of directors of Aril Pharma Limited
Aril Pharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Chopra | Additional Director | 12 Jan 2009 | 17 Years 9 Months | As last reported |
| Satish Surana Also directs: Raja Antibiotics Limited, Angeas Health Care Limited | Additional Director | 24 Aug 2009 | 17 Years 2 Months | As last reported |
| Vaibhav Purnandu Jain Also directs: Althea Unilife LLP, Althea Pharma Private Limited, Attalika Impex Private Limited and 3 more | Director | 04 Apr 2008 | 18 Years 6 Months | As last reported |
| Anupama Purnandu Jain | Director | 30 Sep 2006 | 20 Years 0 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2004 | 80027280 | State Bank of India | ₹9 Cr | Satisfied | |
| 23 Jan 2004 | 90226471 | State Bank of India | ₹6 Cr | Satisfied | |
| 23 Jan 2004 | 80027279 | State Bank of India | ₹4 Cr | Satisfied |
To see the full charge records of Aril Pharma Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Aril Pharma Limited has 6 court cases on record: 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Aquatic Remedies Private Limited | Disposed |
| Bombay High Court | Commercial suit | Filed against the company by Aquatic Remedies Private Limited | Disposed |
| Bombay High Court | Company petition | Filed against the company by Black Rose Industries Ltd. | Disposed |
| Bombay High Court | Company petition | Filed against the company by M/S.Medi Pharma Drug House, | Disposed |
| Bombay High Court | Company petition | Filed against the company by M/S. Medi Pharma Drug House | Disposed |
To see the full case history of Aril Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aril Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aril Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aril Pharma Limited has 9 board changes on record since 2006: 4 appointments and 5 cessations. The latest: Satish Surana ceased to be Additional Director on 24 Jul 2014.
6 earlier events are in the company report.
Frequently asked questions
Aril Pharma is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Aril Pharma is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 November 2002 and is registered under CIN U33110MH2002PLC137788. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Aril Pharma has 4 current directors:
- Vijay Kumar Chopra - Additional Director
- Satish Surana - Additional Director
- Vaibhav Purnandu Jain - Director
- Anupama Purnandu Jain - Director
The latest financial statements of Aril Pharma on record with the MCA are for the year ended 31 March 2011. Its last annual general meeting was held on 30 September 2011. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Aril Pharma is U33110MH2002PLC137788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aril Pharma has no open charges and satisfied charges of ₹19 Cr as per latest MCA filings.
Aril Pharma has 6 court cases on record: 6 filed against it. Most are in the high courts.
Aril Pharma was incorporated on 06 November 2002. It is registered with the Registrar of Companies, Mumbai.
Satish Surana ceased to be Additional Director on 24 Jul 2014. Yashwant Surana ceased to be Director on 01 Oct 2011. Satish Surana was appointed as Additional Director on 24 Aug 2009. Aril Pharma has 9 board changes on record in total.
The registered office of Aril Pharma is at C – 302 Crystal Plaza Andheri Link Road Andheri West, Mumbai, Maharashtra, India – 400053.